Lawyer profile
Robert Bulte
Clifford Chance
- Firm
- Clifford Chance
- Practice
- Corporate, Corporate M&A, Global Financial Markets
- Office
- Amsterdam
- Active in the record
- 2022 to 2025
Deal experience
Deals
9 announced deals in the record Clifford Chance advises underwriters on ONWARD Medical’s €50 million capital increase 29 Oct 2025
Clifford Chance advises the underwriters on Avantium’s €84.8 million equity raise 6 Oct 2025
Clifford Chance advises dsm-firmenich on the sale of its stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion 14 Feb 2025
Clifford Chance advises Charme Capital Partners on the envisaged acquisition of Centogene 19 Nov 2024
Clifford Chance advises Equistone on the intended sale of Heras to Garda Group 19 Jul 2024
Clifford Chance advises dsm-firmenich on the sale of its yeast extract business to Lesaffre 14 Jun 2024
Clifford Chance advises Triton on its intended acquisition of V&N Group from VolkerWessels, which includes Visser & Smit Hanab, VolkerWessels Telecom and Homij 8 Apr 2024
Clifford Chance advises Rivean Capital on the intended acquisition of Wilvo Group 17 Nov 2023
Clifford Chance advises Rabobank on the financing of two solar parks in Denmark 18 Nov 2022
Deal alerts PRO
Get an email when Robert Bulte is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile